{
    "title": "Sanofi, GSK score late win with EU COVID booster approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11413193/EU-regulator-approves-Sanofi-GSKs-COVID-shot-Beta-variant-booster.html",
    "date": "2022-11-10",
    "keywords": [
        "shot",
        "beta",
        "sanofi",
        "vaccine",
        "booster",
        "gsk",
        "approval",
        "covid19",
        "variant",
        "omicron",
        "virus",
        "protection",
        "burger",
        "union",
        "development",
        "agency",
        "year",
        "time",
        "thursday",
        "partner",
        "drawnout",
        "effort",
        "pair",
        "fall",
        "brand",
        "name",
        "course",
        "vaccination",
        "drugmaker",
        "advance",
        "purchase",
        "company",
        "britain",
        "contingent",
        "ingredient",
        "response",
        "contrast",
        "immune",
        "system",
        "coronavirus",
        "africa",
        "mid2020",
        "delta",
        "protein",
        "technology",
        "mrna",
        "approach",
        "breakthrough",
        "statement",
        "blood",
        "analysis",
        "dose",
        "pfizer",
        "firstgeneration",
        "research",
        "solution",
        "pandemic",
        "head",
        "work",
        "generation",
        "candidate",
        "inc",
        "lead",
        "version",
        "june",
        "latestage",
        "trial",
        "meaning",
        "wuhan",
        "strain",
        "monovalent",
        "reporting",
        "pushkala",
        "aripaka",
        "bengaluru",
        "ludwig",
        "frankfurt",
        "editing",
        "potter",
        "jonathan",
        "oatis"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}